Our CEO Kono gives an oral presentation at the SNIS 21st Annual Meeting

We are pleased to announce that our CEO Kono gave an oral presentation at the SNIS 21st Annual Meeting.

■About the SNIS 21st Annual Meeting Held from July 22 to 26, 2024 in Colorado, USA, it is an international academic meeting in neuroendovascular therapy. https://snisannualmeeting.org/ Our CEO Kono gave an oral presentation. Jul 24, 15:15 — Real-time AI-assisted Liquid Embolization for AVM, Dural AVF, Meningioma, and Chronic Subdural Hematoma: A Preliminary Experience